Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Sevoflurane for LMA Removal in Children
NCT03553082Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- May 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propofol, sponsored by American University of Beirut Medical Center. Primary endpoint: Respiratory adverse outcomes at 2 hours. Started May 2018; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on NCT03553082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553082.